Renal pro-inflammatory cytokine gene expression in diabetic nephropathy:: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration

被引:187
|
作者
Navarro, Juan F.
Milena, Francisco J.
Mora, Carmen
Leon, Candelaria
Garcia, Javier
机构
[1] Hosp Univ Nuestra Senora Candelaria, Serv Nefrol, ES-38010 Tenerife, Spain
[2] Hosp Univ Nuestra Senora Candelaria, Res Unit, ES-38010 Tenerife, Spain
[3] Hosp Univ Nuestra Senora Candelaria, Clin Biochem Serv, ES-38010 Tenerife, Spain
[4] Spanish Natl Res Council, Madrid, Spain
关键词
angiotensin II; diabetic nephropathy; enalapril; interleukin; 1; 6; pentoxifylline; tumor necrosis factor-alpha;
D O I
10.1159/000098004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies have shown a role for inflammation in the pathogenesis of diabetic nephropathy (DN). Tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 and IL-6 are cytokines with a prevalent pro-inflammatory activity. Our objective was to study the renal gene expression of TNF-alpha, IL-1 and IL-6 in DN and their relationship with renal damage assessed by urinary albumin excretion (UAE). In addition, we also investigated the effect of angiotensin-converting enzyme inhibition and pentoxifylline (PTF) administration on these parameters. Methods: After streptozotocin-induced diabetes, rats received either no treatment or therapy with enalapril (EN) or PTF for 8 weeks. Renal expression of proinflammatory cytokines was evaluated by real-time polymerase chain reaction. Urinary cytokine excretion and albuminuria were also evaluated. Results: Renal cortical mRNA expression for TNF-alpha, IL-1 and IL-6 in untreated diabetic rats was 2.4-, 1.2- and 3.4-fold higher than in non-diabetic rats. Kidney weight and UAE were significantly associated with renal mRNA expression of TNF-alpha and IL-6. Both EN and PTF administration virtually abrogated the overexpression of TNF-alpha, IL-1 and IL-6, which was associated with a reduction in kidney weight and urinary albumin excretion. Conclusion: The renal expression of the main pro-inflammatory cytokines TNF-alpha, IL-1 and IL-6 is increased in DN, which is significantly associated with UAE. EN and PTF administration prevented this enhanced expression, leading to a decrease in urinary cytokine excretion and a reduction in albuminuria. These findings provide novel insight into the pathogenic mechanisms of DN, supporting the hypothesis that inflammatory mechanisms play a role in the renal injury secondary to diabetes mellitus. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:562 / 570
页数:9
相关论文
共 50 条
  • [31] EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON NEPHROPATHY IN PATIENTS WITH A REMNANT KIDNEY
    NOVICK, AC
    SCHREIBER, MJ
    UROLOGY, 1995, 46 (06) : 785 - 789
  • [32] The effect of angiotensin-converting enzyme inhibition on inflammatory and angiogenic factors in hypercholesterolemia
    Maryam Mahmoudabady
    Narges Kazemi
    Saeed Niazmand
    Seyyed Abdolrahim Rezaee
    Mohammad Soukhtanloo
    Mahmoud Hosseini
    Pharmacological Reports, 2015, 67 : 837 - 841
  • [33] The effect of angiotensin-converting enzyme inhibition on inflammatory and angiogenic factors in hypercholesterolemia
    Mahmoudabady, Maryam
    Kazemi, Narges
    Niazmand, Saeed
    Rezaee, Seyyed Abdolrahim
    Soukhtanloo, Mohammad
    Hosseini, Mahmoud
    PHARMACOLOGICAL REPORTS, 2015, 67 (05) : 837 - 841
  • [34] Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
    Mehdi, Uzma F.
    Adams-Huet, Beverley
    Raskin, Philip
    Vega, Gloria L.
    Toto, Robert D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (12): : 2641 - 2650
  • [35] The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy
    Kamper, AL
    HolsteinRathlou, NH
    Leyssac, PP
    Strandgaard, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (06) : 822 - 831
  • [36] Dual beneficial effect of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in diabetic nephropathy
    Ljubic, S
    Bozikov, J
    Kljajlc, K
    Pavlic-Renar, I
    Vucic-Lovrencic, M
    Metelko, Z
    DIABETES, 2005, 54 : A199 - A199
  • [37] Synergistic effects of angiotensin-converting enzyme and angiotensinogen gene polymorphism on the risk of diabetic nephropathy
    Doi, Y
    Yosinari, M
    Yoshizumi, H
    Wakisaka, M
    Fujishima, M
    DIABETES, 1996, 45 : 694 - 694
  • [38] Angiotensin-converting enzyme 2 (ACE2) gene and protein expression in diabetic patients without nephropathy
    Amao, Olusegun L.
    KIDNEY INTERNATIONAL, 2009, 75 (10) : 1118 - 1119
  • [39] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION - RENAL ASPECTS
    HOLLENBERG, NK
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 : S40 - S44
  • [40] RENAL RESPONSE TO ANGIOTENSIN-CONVERTING ENZYME-INHIBITION
    HOLLENBERG, NK
    AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06): : 1425 - 1429